Outlook Therapeutics appoints Kevin Lundquist as CFO
Outlook Therapeutics appointed Kevin Lundquist as chief financial officer as it prepares for a U.S. commercial launch of LYTENAVA.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Outlook Therapeutics appoints CFO Kevin Lundquist
Outlook Therapeutics appointed Kevin Lundquist as chief financial officer as it prepares for a U.S. commercial launch of LYTENAVA.